Reversal of long-term dendritic spine alterations in Alzheimer disease models
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Synapse loss is strongly correlated with cognitive impairment in Alzheimer's disease (AD). We have previously reported the loss of dendritic spines and the presence of dystrophic neurites in both the hippocampi of transgenic mice overexpressing amyloid precursor protein (APP) and in the human brain affected with AD. In the studies reported here we have asked whether the acute alterations in dendritic spines induced by Aβ, as well as the chronic loss of spine density seen in hAPP transgenic mice, are reversible by treatments that restore the cAMP/PKA/CREB signaling pathway or proteasome function to control levels. The results show that both rolipram and TAT-HA-Uch-L1 restore spine density to near control conditions, even in elderly mice. The results suggest that changes in dendritic structure and function that occur after Aβ elevation are reversible even after long periods of time, and that one could envision therapeutic approaches to AD based on this restoration that could work independently of therapies aimed at lowering Aβ levels in the brain.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, at least some evidence suggests structural and functional alterations may be reversible pharmacologically, opening new therapeutic directions in Alzheimer’s disease98.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [98]
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397 · cited 3×
“Terry RD, et al. (1991) Physical basis of cognitive alterations in Alzheimer’s disease: Synapse loss is the major correlate of cognitive impairment.”
BackgroundCorrelative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210 · cited 2×
“Double transgenic APP/PS1 mice were obtained by crossing hemizygous transgenic mice (HuAPP695SWE; line tg2576) expressing mutant human APP K670N, M671L (35) with hemizygous PS1 mice that express mutant human PS1M146V (line 6.2) (36).”
BackgroundInfluentialPathways towards and Away from Alzheimer’s Disease
Mattson, M. P. (2004) · Nature · doi:10.1038/nature02621 · Cited by 3,052 · cited 2×
“The changes confirm our earlier studies showing similar changes in both J20 single transgenic and APP/PS1 double transgenic animals and in human AD brain (1).”
BackgroundResultAlzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516 · cited 1×
“The development of A plaques has been successfully achieved in transgenic mice overexpressing mutated forms of APP (4) and is greatly accelerated in transgenic models overexpressing mutated forms of both APP and PS1 (5).”
BackgroundWolfe, M. S., Xia, W., Ostaszewski, B. L., Diehl, T. S., Kimberly, W. T., & Selkoe, D. J. (1999) · Nature · doi:10.1038/19077 · Cited by 1,916
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856
Matsuzaki, M., Ellis-Davies, G. C. R., Nemoto, T., Miyashita, Y., Iino, M., & Kasai, H. (2001) · Nature Neuroscience · doi:10.1038/nn736 · Cited by 1,802
Shankar, G. M., Bloodgood, B. L., Townsend, M., Walsh, D. M., Selkoe, D. J., & Sabatini, B. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4970-06.2007 · Cited by 1,592 · cited 1×
“Dendritic spine loss is also seen in the brains of PDAPP, Tg2576, and J20 APP transgenic mice (27, 28) and in hippocampal slices treated with A (29, 30).”
BackgroundIncreased amyloid-β42(43) in brains of mice expressing mutant presenilin 1
Duff, K., Eckman, C., Zehr, C., Yu, X., Prada, C.-M., Perez-tur, J., Hutton, M., Buee, L., Harigaya, Y., Yager, D., et al. (1996) · Nature · doi:10.1038/383710a0 · Cited by 1,465
Cited by
Items 101–200 of 238
Cui, S., Yang, M., Zhang, Y., Zheng, V., Zhang, H., Gurney, M. E., Xu, Y., & O’Donnell, J. M. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.259986 · Cited by 47
“Rolipram is protective in models of in vitro amyloid beta (Ab) neurotoxicity, prevents disease progression in amyloid protein precursor transgenic mice, and preserves synaptic connections (Vitolo et al., 2002; Gong et al., 2004; Shrestha et al., 2006; Smith et al., 2009).”
BackgroundSmall Molecule Allosteric Modulators of Phosphodiesterase 4
Gurney, M. E., Burgin, A. B., Magnússon, Ó. Þ., & Stewart, L. J. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-17969-3_7 · Cited by 46
“…animal models of short- and long-term memory formation (Blokland et al. 2006), enhances long-term potentiation of synaptic efficacy (Vecsey et al. 2009), and is protective in transgenic models of Alzheimer’s disease (Gong et al. 2004; Smith et al. 2009) and Huntington’s disease (DeMarch 2008).”
BackgroundRudobeck, E., Bellone, J. A., Szűcs, A. L., Bonnick, K., Mehrotra, S., Badaut, J., Nelson, G. A., Hartman, R. E., & Vlkolinský, R. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186168 · Cited by 45
Pharmacological rescue in patient iPSC and mouse models with a rare DISC1 mutation
Kim, N.-S., Wen, Z., Liu, J., Zhou, Y., Guo, Z., Xu, C., Lin, Y.-T., Yoon, K., Park, J., Cho, M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21713-3 · Cited by 49
Schaler, A. W., Runyan, A. M., Clelland, C. L., Sydney, E. J., Fowler, S. L., Figueroa, H. Y., Shioda, S., Santa-Maria, I., Duff, K. E., & Myeku, N. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.aba7394 · Cited by 42
Zhao, P., Hill, M., Liu, S., Chen, L., Bangalore, L., Waxman, S. G., & Tan, A. M. (2016) · Journal of Neurophysiology · doi:10.1152/jn.01057.2015 · Cited by 43
“…including epilepsy, stroke, posttraumatic stress disorder (PTSD), autism spectrum disorder, mental retardation, dementia, and chronic substance abuse or addiction (Dindot et al. 2008; Duman and Duman 2015; Halpain et al. 2005; Kyzar and Pandey 2015; Moench and Wellman 2015; Smith et al. 2009).”
BackgroundThibault, O., Pancani, T., Landfield, P. W., & Norris, C. M. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.01.004 · Cited by 40
“While evidence for impaired activation of PKA and/or PKA dependent processes has been reported in AD mice and/or cell cultures treated with Aβ [33, 34], calcineurin activity and signaling are upregulated in the same or similar models [35–38].”
ResultHeinisch, J. J., & Brandt, R. (2016) · Microbial Cell · doi:10.15698/mic2016.04.489 · Cited by 42
DMSO modulates CNS function in a preclinical Alzheimer's disease model
Penazzi, L., Lorengel, J., Sündermann, F., Golovyashkina, N., Marre, S., Mathis, C., Lewejohann, L., Brandt, R., & Bakota, L. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.10.020 · Cited by 42
Sivalingam, K., Cirino, T. J., McLaughlin, J. P., & Samikkannu, T. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02131-w · Cited by 42
Atluri, V. S. R., Pilakka‐Kanthikeel, S., Samikkannu, T., Sagar, V., Kurapati, K. R. V., Saxena, S. K., Yndart, A., Raymond, A., Ding, H., Hernandez, O., et al. (2014) · Molecular Brain · doi:10.1186/1756-6606-7-37 · Cited by 38
“Established protocol to stain the neuronal cells and measurement of the spine density (in all the control and test group neuronal cells) was used with few modifications [13,74,77-81].”
MethodAmniotic Mesenchymal Stem Cells Decrease Aβ Deposition and Improve Memory in APP/PS1 Transgenic Mice
Zheng, X., Wan, Q.-Q., Zheng, C.-Y., Zhou, H., Dong, X., Deng, Q., Yao, H., Fu, Q., Gao, M., Yan, Z., et al. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2226-8 · Cited by 40
“Furthermore, the alterations in dendritic spine density closely parallel the inhibition of long-term potentiation (LTP) and the development of behavioral deficits in APP/PS1 mice [37].”
BackgroundInfluentialApremilast Alters Behavioral Responses to Ethanol in Mice: I. Reduced Consumption and Preference
Blednov, Y. A., Costa, A. J. D., Tarbox, T., Ponomareva, O. Y., Messing, R. O., & Harris, R. A. (2018) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13616 · Cited by 40
“In addition to drug addiction, PDE4 inhibitors have been investigated as potential therapeutics in diverse central nervous system (CNS) disorders such as depression, anxiety, schizophrenia, Parkinson’s disease, and Alzheimer’s disease (Halene and Siegel, 2007; Kanes et al., 2007; Smith et al., 2009).”
BackgroundResveratrol as a Protective Molecule for Neuroinflammation: A Review of Mechanisms
Renaud, J., & Martinoli, M. (2014) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201015666140617101332 · Cited by 37
“Furthermore, PDE4 inhibitors were tested in animal models and results demonstrate a potential for these pharmacological compounds in improving memory [128] and protecting against aging-related diseases such as AD [129] and PD [130].”
BackgroundYe, J., Yin, Y., Liu, H., Fang, L., Tao, X., Wei, L., Zuo, Y., Yin, Y., Ke, D., & Wang, J. (2019) · Aging Cell · doi:10.1111/acel.13055 · Cited by 38
Dever, S. M., Rodriguez, M., Lapierre, J., Costin, B. N., & El‐Hage, N. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00653 · Cited by 35
“Relative levels of immunofluorescent intensity were quantified using plugin algorithm software for ImageJ [National Institutes of Health (NIH); Bethesda, MD, USA].”
MethodElder, M. K., Erdjument‐Bromage, H., Oliveira, M. M., Mamcarz, M., Neubert, T. A., & Klann, E. (2021) · Communications Biology · doi:10.1038/s42003-021-02324-6 · Cited by 40
Zhao, X. S., Zhai, S., An, M.-S., Wang, Y., Yang, Y.-F., Ge, H.-Q., Liu, J., & Pu, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078220 · Cited by 40
“As a result, spine density restoration has been proposed as a potential therapeutic approach for treating neurodegenerative diseases [46].”
BackgroundSchaler, A. W., & Myeku, N. (2018) · Translational Research · doi:10.1016/j.trsl.2017.11.004 · Cited by 36
“Accumulating evidence from several animal models indicates that PDE inhibitors show cognitive enhancing capacity.(25,42-49) In particular, cilostazol, an FDAapproved PDE3 inhibitor, has been shown to decrease amyloid beta accumulation and protect against betaamyloid-induced cognitive deficits in animal models.”
BackgroundAIM2 deletion promotes neuroplasticity and spatial memory of mice
Chen, J., Shu, S., Chen, Y., Liu, Z., Yu, L., Yang, L., Xu, Y., & Zhang, M. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.07.011 · Cited by 34
Wang, Z., Zhang, Y., Zhang, H., & Li, Y. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140826115559 · Cited by 36
“This is further supported by findings using genetically modified mouse models of AD, including amyloid precursor protein (APP)/presenilin-1 (PS1) double transgenic mice [178, 179], transgenic mice (Tg2576) overexpressing the Swedish mutation of the human APP [180], and mice expressing both human mutant PS1 and APP (PS…”
BackgroundNanostructured Antagonist of Extrasynaptic NMDA Receptors
Savchenko, A., Braun, G. B., & Molokanova, E. (2016) · Nano Letters · doi:10.1021/acs.nanolett.6b01988 · Cited by 34
Sagar, V., Pilakka‐Kanthikeel, S., Atluri, V. S. R., Ding, H. Y., Arias, A. Y., Jayant, R. D., Kaushik, A. K., & Nair, M. (2015) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2015.2108 · Cited by 31
APP-Mediated Signaling Prevents Memory Decline in Alzheimer’s Disease Mouse Model
Deyts, C., Clutter, M., Pierce, N., Chakrabarty, P., Ladd, T. B., GODDI, A. A., Rosario, A. M., Cruz, P. E., Vetrivel, K. S., Wagner, S. L., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.03.087 · Cited by 32
“, 2002), and restore synaptic structural alterations (Smith et al., 2009).”
BackgroundGeometric Control of Frequency Modulation of cAMP Oscillations due to Calcium in Dendritic Spines
Ohadi, D., & Rangamani, P. (2019) · Biophysical Journal · doi:10.1016/j.bpj.2019.10.004 · Cited by 33
Juhász, G. D., Földi, I., & Penke, B. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.02.008 · Cited by 31
“In fact, one of the earliest effects of Ab is the decrease in the size of synapses and the disappearance synapses from dendritic spines (Smith et al., 2009).”
BackgroundLu, M., Zhao, X., Xu, D.-E., Chen, J.-B., Ji, W., Huang, Z.-P., Pan, T.-T., Xue, L., Wang, F., Li, Q., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200010 · Cited by 30
Bastian, F. (2014) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/nen.0000000000000033 · Cited by 22
Martínez‐Cué, C., & Rueda, N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186906 · Cited by 26
“The disturbances in cAMP/PKA-dependent CREB signalling have been demonstrated to be responsible for Aβ-induced synaptic loss and cognitive impairments [82,85,86].”
BackgroundLocalized molecular chaperone synthesis maintains neuronal dendrite proteostasis
Alecki, C., Rizwan, J., Le, P., Jacob‐Tomas, S., Comaduran, M. F., Verbrugghe, M., Xu, J. M. S., Minotti, S., Lynch, J., Biswas, J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-55055-7 · Cited by 28
“Sustaining functional synapses is essential for neuronal network functions, and stress on their proteomes would contribute to the impaired connectivity that underlies loss of function early in neurodegenerative disorders, prior to neuronal death 139 – 141 .”
NO-donor thiacarbocyanines as multifunctional agents for Alzheimer’s disease
Chegaev, K. Y., Federico, A., Marini, E., Rolando, B., Fruttero, R., Morbin, M., Rossi, G., Fugnanesi, V., Bastone, A., Salmona, M., et al. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.05.050 · Cited by 28
Sell, G. L., Schaffer, T. B., & Margolis, S. S. (2017) · Journal of Clinical Investigation · doi:10.1172/jci85504 · Cited by 28
“Throughout life, hippocampal dendritic spines undergo continual dynamic changes that closely correlate with learning and memory and are profoundly affected in AD (15, 16).”
BackgroundLu, M., Ji, W., Xu, D.-E., Yao, P.-P., Zhao, X., Wang, Z., Fang, L., Huang, R., Lan, L.-J., Chen, J.-B., et al. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2018.09.012 · Cited by 26
Terahertz photons promote neuron growth and synapse formation through cAMP signaling pathway
Zhong, Y., Yu, Y., Li, Y., Yin, J., Sun, Y., Jiang, R., & Chang, C. (2025) · PhotoniX · doi:10.1186/s43074-025-00165-8 · Cited by 24
Khorshidahmad, T., Tabrizian, K., Vakilzadeh, G., Nikbin, P., Moradi, S., Hosseini-Sharifabad, A., Roghani, A., Naghdi, N., & Sharifzadeh, M. S. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.12.028 · Cited by 24
Mi, Z., Liu, H., Rose, M. E., Ma, X., Reay, D. P., Ma, J., Henchir, J. J., Dixon, C. E., & Graham, S. H. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113524 · Cited by 26
“UCHL1 also regulates synaptic function and long term potentiation and has been implicated in memory function (Chen et al., 2010; Gong et al., 2006; Smith et al., 2009; Zhang et al., 2014).”
BackgroundBate, C., & Williams, A. (2015) · Biology · doi:10.3390/biology4030591 · Cited by 21
Phosphodiesterase-4 inhibition restored hippocampal long term potentiation after primary blast
Vogel, E. W., Morales, F. N., Meaney, D. F., Bass, C. R., & Morrison, B. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.03.025 · Cited by 23
“…was effective in improving outcome in someexperimentalmodels of TBI and also reduced cognitive impairments associated with Alzhemer's disease, schizophrenia and aging (Gong et al., 2004; Maxwell et al., 2004; Smith et al., 2009; Titus et al., 2014; Wiescholleck and Manahan-Vaughan, 2012).”
BackgroundPuri, S., & Hsu, S. D. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.166879 · Cited by 24
May, L. M., Anggono, V., Gooch, H. M., Jang, S. E., Matusica, D., Kerbler, G. M., Meunier, F. A., Sah, P., & Coulson, E. J. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00455 · Cited by 23
“These Aβ-mediated changes, which include the loss of dendritic spines and neurites (Mucke et al., 2000; Smith et al., 2009; Perez-Cruz et al., 2011), have been proposed to cause the cognitive decline, which precedes neuronal death in Alzheimer’s disease (Ondrejcak et al., 2010; Palop and Mucke,…”
BackgroundSerine-arginine protein kinases: new players in neurodegenerative diseases?
Chan, C. B., & Ye, K. (2013) · Reviews in the Neurosciences · doi:10.1515/revneuro-2013-0014 · Cited by 23
Plasticity-related Gene 5 Promotes Spine Formation in Murine Hippocampal Neurons
Coiro, P., Stoenica, L., Strauß, U., & Bräuer, A. U. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.597880 · Cited by 23
“Protrusion length, spine head diameter, and spine area were measured as described previously (25).”
MethodBorbély, E., Horváth, J., Furdan, S., Bozsó, Z., Penke, B., & Fülöp, L. (2014) · BioMed Research International · doi:10.1155/2014/345305 · Cited by 21
“The loss of dendritic spines and the presence of dystrophic neurites have been reported both in the amyloid precursor protein (APP) overexpressing transgenic mouse model of AD and in the AD-affected human brain [2, 8, 19, 20].”
BackgroundMorphology and Transport in Eukaryotic Cells
Agrawal, A., Scott, Z. C., & Koslover, E. F. (2022) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-111121-103956 · Cited by 23
Szatmari, E. M., Moran, C., Cohen, S. J., Jacob, A., Parra-Bueno, P., Kamasawa, N., Guerrero‐Given, D., Klein, M., Stackman, R. W., & Yasuda, R. (2020) · eNeuro · doi:10.1523/eneuro.0111-20.2020 · Cited by 19
“…disorders, including Alzheimer’s disease (AD), suggesting the importance of spine plasticity in normal brain function (Jacobsen et al., 2006; Smith et al., 2009; van Spronsen and Hoogenraad, 2010; Wei et al., 2010; Perez- Received March 23, 2020; accepted October 1, 2020; First published…”
BackgroundIntegration of multiscale dendritic spine structure and function data into systems biology models
Mancuso, J. J., Cheng, J., Yin, Z., Gilliam, J. C., Xia, X., Li, X., & Wong, S. T. C. (2014) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2014.00130 · Cited by 21
“Additionally, treatments that reduce the cognitive symptoms of neurodegenerative disease also reverse spine pathology (Smith et al., 2009).”
BackgroundEarly hippocampal hyperexcitability and synaptic reorganization in mouse models of amyloidosis
Ray, A., Loghinov, I., Ravindranath, V., & Barth, A. L. (2024) · iScience · doi:10.1016/j.isci.2024.110629 · Cited by 18
Borreca, A., Latina, V., Corsetti, V., Middei, S., Piccinin, S., Valle, F. D., Bussani, R., Ammassari‐Teule, M., Nisticò, R., Calissano, P., et al. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0974-3 · Cited by 18
Clapcote, S. J. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-58811-7_5 · Cited by 18
Zhang, J., Yu, L., Yang, H., Hui, Z., Jiang, S., Chen, L., Zhao, Y., Wang, S., Liu, Y., & Xu, Y. (2018) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-018-2237-2 · Cited by 19
“The development of dendrites and the number of dendritic spines can both affect synaptic function in AD mice [28].”
BackgroundTranscriptional Responses of Cultured Rat Sympathetic Neurons during BMP-7-Induced Dendritic Growth
Garred, M. M., Wang, M. M., Guo, X., Harrington, C. A., & Lein, P. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021754 · Cited by 18
“Examples include Jagged1, a ligand for the Notch system that has been implicated in controlling multiple aspects of dendritic growth [75,92,93]; Mark1, a gene whose optimal levels of expression is required for proper dendrite length [94]; Ngfr (p75), which has complex roles in dendrite stabilization and likely modulat…”
BackgroundCui, Z., Guo, Z., Wei, L., Zou, X., Zhu, Z., Liu, Y., Wang, J., Chen, L., Wang, D., & Ke, Z. (2022) · Pain · doi:10.1097/j.pain.0000000000002648 · Cited by 17
“38 Neuropathological alterations are most likely to be detected at 4-m AD modeling mice 69,88 ; our study which is trying to uncover the potential mechanism of chronic pain in AD modeling animal is conducted on3and6mmicebecausetheADmiceof6mand9mgroupsboth show altered pain response in von Frey…”
Wang, Q., Wu, S., Zou, J., Liang, X., Mou, C., Zheng, P., & Chi, Y. R. (2023) · Nature Communications · doi:10.1038/s41467-023-40645-8 · Cited by 18
Kalirin‐7 prevents dendritic spine dysgenesis induced by amyloid beta‐derived oligomers
Xie, Z., Shapiro, L. P., Cahill, M. E., Russell, T. A., Lacor, P. N., Klein, W. L., & Penzes, P. (2019) · European Journal of Neuroscience · doi:10.1111/ejn.14311 · Cited by 17
Bourne, K. Z., Natarajan, C., Perez, C., Tumurbaatar, B., Taglialatela, G., & Krishnan, B. (2019) · Scientific Reports · doi:10.1038/s41598-019-54974-6 · Cited by 17
Gerasimov, E., Борисович, Б. И., & Власова, О. Л. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24129969 · Cited by 14
Wei, J., Ma, X., Nehme, A., Cui, Y., Zhang, L., & Qiu, S. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.954266 · Cited by 16
“Synaptic function may be preserved by preventing mechanisms of synapse degeneration and/or promoting mechanisms favoring homeostasis or regeneration (Smith et al., 2009).”
BackgroundBenzothiazole Amphiphiles Promote the Formation of Dendritic Spines in Primary Hippocampal Neurons
Cifelli, J. L., Dozier, L. E., Chung, T. S., Patrick, G. N., & Yang, J. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.701482 · Cited by 16
Wolf, C., An, Y., Tanaka, T., Bilgel, M., Gonzalez, C., Kitner‐Triolo, M. H., & Resnick, S. M. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00142 · Cited by 15
“…aged adult mice, following inhibition the reactivation of CREB signaling pathways in the hippocampus has been consistently shown to increase CREB-dependent transcription and rescue deficient neuroplasticity and memory (Genoux et al., 2002; Smith et al., 2009; Yiu et al., 2011; Adlard et al., 2014).”
BackgroundInfluentialDelivery of Neurotherapeutics Across the Blood Brain Barrier in Stroke
Hu, X., Zhang, M., Leak, R. K., Gan, Y., Li, P., Gao, Y., & Chen, J. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212802002715 · Cited by 14
“Alzheimer model Restores spine density [138]”
Trapping in and Escape from Branched Structures of Neuronal Dendrites
Jose, R., Santen, L., & Shaebani, M. R. (2018) · Biophysical Journal · doi:10.1016/j.bpj.2018.09.029 · Cited by 13
Is CREB the Angry Bird that Releases Memory in Alzheimer's?
Wang, A. R., & Bibb, J. A. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.126 · Cited by 13
Manap, A. S. A., Madhavan, P., Vijayabalan, S., Chia, A. Y. Y., & Fukui, K. (2020) · PeerJ · doi:10.7717/peerj.10003 · Cited by 12
Natarajan, C., Cook, C., Ramaswamy, K., & Krishnan, B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043372 · Cited by 12
Phosphodiesterase 4 Inhibition in Neuropsychiatric Disorders Associated with Alzheimer’s Disease
Chen, J., Zhu, Z., Xu, F., Dou, B., Sheng, Z., & Xu, Y. (2025) · Cells · doi:10.3390/cells14030164 · Cited by 12
Nandi, S., Alviña, K., Lituma, P. J., Castillo, P. E., & Hébert, J. M. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.11.017 · Cited by 10
“Sholl analyses were carried out using 40 μm concentric circular bins from soma while dendritic spine density was assessed by the Image J software (Bicanic et al., 2017; Sholl, 1953; Smith et al., 2009).”
Shevelev, O. B., Rykova, V. I., Fedoseeva, L. A., Leberfarb, E. Y., Dymshits, G. M., & Kolosova, N. G. (2012) · Biochemistry (Moscow) · doi:10.1134/s0006297912010063 · Cited by 10
Izumi, H., Kawahata, K., Shinoda, Y., Helmstetter, F. J., & Fukunaga, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113833 · Cited by 13
“Aβ treatment decreases dendritic spine density in neurons in culture [54,55] and acute brain slices [56].”
BackgroundZCCHC17 Modulates Neuronal RNA Splicing and Supports Cognitive Resilience in Alzheimer's Disease
Bartosch, A. M. W., Youth, E. H. H., Hansen, S., Wu, Y., Buchanan, H. M., Kaufman, M. E., Xiao, H., Koo, S. Y., Ashok, A., Sivakumar, S., et al. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.2324-22.2023 · Cited by 10
A Systems Approach to Drug Discovery in Alzheimer's Disease
Shelanski, M. L., Shin, W., Aubry, S., Sims, P. A., Alvarez, M. J., & Califano, A. (2015) · Neurotherapeutics · doi:10.1007/s13311-014-0335-5 · Cited by 9
Self-citationThe Past, Present, and Future of Phosphodiesterase-4 Modulation for Age-Induced Memory Loss
Hansen, R., & Zhang, H. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-58811-7_7 · Cited by 11
Ness, N., & Schultz, S. R. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1009115 · Cited by 10
“In APP/PS1 mouse models, progressive reductions in spine density on the distal dendrites of CA1 pyramidal neurons, which are innervated by EC layer III, have been detected at 4–15 months of age [64], with a similar extent of loss occurring in 5xFAD models [65].”
InfluentialBoddapati, S. N. M., Tamminana, R., Senapathi, H. J., Kola, A. E., Ansari, S. A., Kapavarapu, R., Bollikolla, H. B., & Jonnalagadda, S. B. (2025) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2025.141409 · Cited by 8
Choi, J.-Y., Mohibbullah, M., Park, I.-S., Moon, I. S., & Hong, Y. (2017) · Journal of Applied Phycology · doi:10.1007/s10811-017-1116-4 · Cited by 8
“1.45) was used (Smith et al. 2009).”
InfluentialMultisite Organic–Inorganic Hybrid Catalysts for the Direct Sustainable Synthesis of GABAergic Drugs
Leyva‐Pérez, A., García, P. G., & Corma, A. (2014) · Angewandte Chemie · doi:10.1002/ange.201403049 · Cited by 8
Jiang, M., Lu, S., Telu, S., & Pike, V. W. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01745 · Cited by 7
Ho, C., Luchetta, J., Nash, B., Festa, L. K., Johnson, J. A., Saçan, A., Jackson, J. G., Sanz-Clemente, A., Brandimarti, R., & Meucci, O. (2025) · Journal of Neuroscience · doi:10.1523/jneurosci.2213-24.2025 · Cited by 7
“Several groups report ways to recover lost spines in models of Alzheimer ’ s disease (Smith et al., 2009) and traumatic brain injury (Xiong et al., 2019), highlighting the continued importance of dendritic spine health across CNS diseases (Smith et al., 2009).”
Hrynchak, M. V., Rierola, M., Golovyashkina, N., Penazzi, L., Pump, W. C., David, B., Sündermann, F., Brandt, R., & Bakota, L. (2020) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2020.00016 · Cited by 7
Emerging concepts towards a translational framework in Alzheimer’s disease
Cozachenco, D., Zimmer, E. R., & Lourenco, M. V. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105246 · Cited by 8
Structural plasticity of dendritic spines
Zhang, S., Wang, J., & Wang, L. (2010) · Frontiers in Biology · doi:10.1007/s11515-010-0011-z · Cited by 7
The role of membranes in function and dysfunction of intrinsically disordered amyloidogenic proteins
Pathak, B. K., Dey, S., Mozumder, S., & Sengupta, J. (2022) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2021.08.001 · Cited by 6
A simple enantioselective route toward (R)- and (S)-Rolipram via anhydride desymmetrization
Ivšić, T., & Hameršak, Z. (2013) · Tetrahedron Asymmetry · doi:10.1016/j.tetasy.2013.01.009 · Cited by 6
Qi, L., Sun, C., Sun, S., Li, A., Hu, Q., Liu, Y., & Zhang, Y. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102775 · Cited by 6
“In the pathological setting, exposure of hippocampal neurons to amyloid Aβ results in a decrease in dendrite diameters (50), which could contribute to defective information processing in Alzheimer’s disease.”
BackgroundMcGirr, A., Lipina, T. V., Mun, H.-S., Georgiou, J., Al-Amri, A. H., Ng, E., Zhai, D., Elliott, C., Cameron, R. T., Mullins, J. G. L., et al. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.263 · Cited by 7
Potential Therapeutic Strategies to Prevent the Progression of Alzheimer to Disease States
Aso, E., & Ferrer, I. (2013) · InTech eBooks · doi:10.5772/54783 · Cited by 5
“[229] Smith DL, Pozueta J, Gong B, Arancio O, Shelanski M.”
Toledano‐Díaz, A., Álvarez, M. I., & Tolédano, A. (2022) · Journal of Central Nervous System Disease · doi:10.1177/11795735221123896 · Cited by 5
Direct evidence for dendritic spine compensation and regeneration in Alzheimer's disease models
Bhembre, N., Boskovic, Z., Willshaw, J. L., Castello-Waldow, T. P., Bonthron, C., Paolino, A., & Opazo, P. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70829 · Cited by 4
“∙ We postulate that synaptic resilience is an active neuronal program rather than a passive byproduct of pathology.”
Sillau, S., Coughlan, C. M., Ahmed, M. M., Nair, K. V., Araya, P., Galbraith, M. D., Ritchie, A. M., Wang, A. C., Elos, M. T., Bettcher, B. M., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102525 · Cited by 5
Li, H., Hua, Q., Cheng, S., Liu, X., Cai, Q., Zhang, J., Peng, T., Li, J., Wang, C., Liang, C., et al. (2024) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/0113862073311518240416070410 · Cited by 4
Hybrid Amyloid Quantum Dot Nano-Bio Assemblies to Probe Neuroinflammatory Damage
Chiang, W., Urban, J. M., Yanchik-Slade, F., Stout, A., Hammond, J. M., Nilsson, B. L., Gelbard, H. A., & Krauss, T. D. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00183 · Cited by 5
The limbic system: influence over motor control and learning
Umphred, D. A., Thompson, M. H., & West, T. M. (2013) · Elsevier eBooks · doi:10.1016/b978-0-323-07586-2.00014-5 · Cited by 6
Toledano‐Díaz, A., Álvarez, M., & Tolédano, A. (2020) · OBM Geriatrics · doi:10.21926/obm.geriatr.2002117 · Cited by 4
Sillau, S., Coughlan, C. M., Ahmed, M. M., Nair, K. V., Araya, P., Galbraith, M. D., Bettcher, B. M., Espinosa, J. M., Chial, H. J., Epperson, N., et al. (2024) · medRxiv · doi:10.1101/2024.07.14.24310223 · Cited by 4
Boosting Brain Clean-Up: Can Targeting UPS Genes Offer Neuroprotection?
Mannan, A., Sharma, A., & Singh, T. G. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05263-z · Cited by 3
“Across these distinct NDDs, a clear pattern emerges where UPS dysfunction, directly or indirectly, impairs CREB signaling [276], highlighting the critical importance of this regulatory axis in maintaining neuronal health and its vulnerability in NDDs. Conversely, studies have also suggested that…”
Grochowska, K. M., Gomes, G. M., Raman, R., Kaushik, R., Sosulina, L., Kaneko, H., Oelschlegel, A. M., Yuanxiang, P., Reyes-Resina, I., Bayraktar, G., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.01.08.898304 · Cited by 3
“function through agents such as rolipram (76, 77) or its analogue GEBR-7b (78).”
BackgroundPeng, T., Zhang, Z., Ding, N., & Zhang, J. (2026) · Neural Plasticity · doi:10.1155/np/6718671 · Cited by 2
“In APP/PS1 and other AD models, voluntary exercise partially restores A β - induced LTP impairments and attenuates aberrantly potentiated Ltd, thereby stabilizing synaptic homeostasis and network function [49, 50].”
The Protective Effects of Ubiquitin C-Terminal Hydrolase L1 on Neurons*
Min, X. I. E., Chen, Q.-C., & Liao, X. (2010) · PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS · doi:10.3724/sp.j.1206.2010.00253 · Cited by 2
Cîrneci, D., & Silaghi-Dumitrescu, R. L. (2013) · PubMed Central · doi:10.3969/j.issn.1673-5374.2013.32.010 · Cited by 2
“3065 spine density and the cAMP/PKA/CREB signaling pathway in Alzheimer’s disease models [9] .”
BackgroundMagnetic Nanoparticle-based Targeted Drug Delivery for Treatment of Neuro-AIDS and Drug Addiction
Sagar, V. (2013) · FIU - Digital Commons (Florida International University) · doi:10.25148/etd.fi13080525 · Cited by 2
Homeostasis of dendritic spines in hippocampal CA1 cells
Mestrallet, C. A. (2011) · UCL Discovery (University College London) · Cited by 3
Metadata
- Authors
- Smith, D. L., Pozueta, J., Gong, B., Arancio, O., & Shelanski, M.
- Affiliations
- Columbia University (US)
- Guy's Hospital (GB)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2009-09-29
- Volume
- 106
- Issue
- 39
- Pages
- 16877-16882
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2743726
- OpenAlex
- W1977390447
- Cited by
- 229
- References
- 42
- Citations by year
- 2026: 1 · 2025: 10 · 2024: 7 · 2023: 9 · 2022: 6 · 2021: 7 · 2020: 21 · 2019: 10 · 2018: 16 · 2017: 20 · 2016: 10 · 2015: 17 · 2014: 22 · 2013: 18 · 2012: 23
- FWCI
- 12.19
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (AG 008700)
- National Institute of Neurological Disorders and Stroke (NS15076, R01NS015076)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, dendritic spines, synaptic loss, amyloid-beta, APP transgenic mice, rolipram, cAMP/PKA/CREB signaling, proteasome function, UCHL1, dystrophic neurites, hippocampus, cognitive impairment
- MeSH terms
- Alzheimer Disease, Animals, Brain, Dendrites, Disease Models, Animal, Hippocampus, Humans, Mice, Transgenic, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Dendritic Spines, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.